已收盘 12-12 16:00:00 美东时间
-6.690
-4.87%
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从35美元升至36美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.75美元升至8美元
12-09 10:32
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
12-05 08:35
今日重点评级关注:B. Riley证券:维持Seabridge Gold"买入"评级,目标价从50美元升至65美元;HC Wainwright & Co.:维持TRX Gold"买入"评级,目标价从1.2美元升至1.4美元
12-03 09:58
U.S. stocks found their footing Tuesday, posting a modest rebound after Monday's pullback as the global bond sell-off sparked by the Bank of Japan finally cooled.
12-03 01:55
Morgan Stanley analyst Kallum Titchmarsh downgrades Inspire Medical Systems (NYSE:INSP) from Overweight to Equal-Weight and raises the price target from $105 to $130.
12-03 01:43
Top Wall Street analysts changed their outlook on these top names. For a comple...
11-27 00:45
今日重点评级关注:HC Wainwright & Co.:维持BiomX"买入"评级,目标价从15美元升至26美元;Clear Street:维持Diversified Energy"买入"评级,目标价从23美元升至25美元
11-26 10:07
Wolfe Research analyst Mike Polark upgrades Inspire Medical Systems (NYSE:INSP) from Peer Perform to Outperform and announces $180 price target.
11-25 23:58
OSCR大涨超22%,白宫计划延长奥巴马医改补贴;加密财库公司BitMine大涨19.6%,持有3%的ETH代币供应量>>
11-25 15:10
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
11-25 10:27